Advanced Respiratory, Inc. is a for-profit medical equipment manufacturer registered to receive federal contract awards since February 2004. The company spec...
Advanced Respiratory Technologies, Inc. | LinkedIn 팔로워 133명 | Advanced Respiratory Technologies, Inc. (ART) is a medical device company that is developing next generation lungs for long term use. A...
Advanced respiratory failure with tracheostomy requirement is common in heart recipients. The aim of the study is to assess the tracheostomy rate after orthotopic heart transplantation and identify...
Advances in Respiratory Medicine, which has been published by MDPI since 2022, serves as a platform for hosting pneumological studies [...]
Home ; Advisory Committees · Committees and Meeting Materials · Medical Devices · Medical Devices Advisory Committee · Anesthesiology and Respiratory Therapy Devices Panel · Roster of the Anesthesiology and Respiratory Therapy Devices Panel
Respiratory Viruses ; We are using our structure-based drug discovery platform to discover pan-viral inhibitors for respiratory viruses such as enterovirus and rhinovirus. Non-polio enteroviruses cause about 10-15 million infections and tens of thousands of hospitalizations each year in the U.S. Most people who get infected with these viruses do not get sick or have mild illness like the common cold; however, even those infected who do not have symptoms can still spread the virus to other people. This makes it is difficult to prevent non-polio ...
관련성이 더 높은 업데이트 ; Zydus Ph ; This September, we are highlighting Pulmonary Fibrosis Awareness Month to honor the approximately 30,000 people living with pulmonary fibrosis in Canada. This disease involves the thickening and scarring of lung tissue, which progressively affects breathing and quality of life. If you or someone you know is affected, it’s important to be aware of the challenges and support available. Let’s raise awareness and offer support to those navigating...
Announces next-generation COVID-19 vaccine candidate as fourth respiratory vaccine to successfully meet its Phase 3 endpoints Expects two more Phase 3 readouts in 2024, including combination vaccin...
of Respiratory Syncytial Virus (RSV) infections and growth in... global Respiratory Syncytial Virus therapeutics market revenue. RSV causes respiratory disorders, with infants and the aging...
The respiratory support system market is expected to witness market growth at a rate of 9.50% in the forecast period of 2021 to 2028. Data Bridge Market Research report on respiratory support system market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market’s growth. The rise in the prevalence of respiratory diseases is escalating the growth of respiratory support system market. ...